By drugs lower LDL cholesterol can reduce medsci.
do?w=%E5%BF%83%E8%A1%80%E7%AE%A1">heart blood vessel disease risk, but may increase type 2 diabetes risk.
do?w=%E5%BF%83%E8%A1%80%E7%AE%A1">heart blood vessels of diabetes
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
This study aims to evaluate the relationship between LDL cholesterol levels and insulin secretion and glucagon levels.
The researchers performed routine blood tests on 3039 subjects who did not receive cholesterol-lowering treatment but had an increased risk of diabetes, as well as an oral glucose tolerance test (OGTT) at 5 time points.
Glucagon concentration, insulin secretion and insulin clearance index are all derived from OGTT.
Researchers found no correlation between LDL cholesterol and fasting glucagon (p=0.
01) or glucagon levels after glucose load (p=0.
07), but the researchers found LDL cholesterol and C peptide-based insulin secretion index (AUCC-peptide (0-30min)/AUC glucose (0-30min): p=0.
06; AUCC-peptide (0-120min)/AUC glucose (0- 120min): p<0.
In contrast, the researchers found that insulin-based insulin secretion index was negatively correlated with LDL concentration (insulin-stimulating index: p=0.
04; utilization index: p=0.
Although, after fasting state and glucose load, there was a positive correlation between LDL cholesterol level and insulin clearance assessed by C peptide and insulin concentration (p<0.
09 and p<0.
The C-peptide-based index reflects insulin secretion independent of liver clearance.
The results of this study indicate that insulin secretion is reduced in the case of low LDL cholesterol.
This may explain why taking cholesterol-lowering drugs is not conducive to blood sugar control .
This may explain why taking cholesterol-lowering drugs is not conducive to blood sugar control
Original source:Original source:
1210/clinem/dgab147" target="_blank" rel="noopener">Low-density lipoprotein cholesterol is associated with insulin secretion .
1210/clinem/dgab147" target="_blank" rel="noopener">Low-density lipoprotein cholesterol is associated with insulin secretion
in this message